nodes	percent_of_prediction	percent_of_DWPC	metapath
Terconazole—Posaconazole—ABCB1—kidney cancer	0.0105	0.292	CrCbGaD
Terconazole—Itraconazole—CYP1A1—kidney cancer	0.0104	0.289	CrCbGaD
Terconazole—Face oedema—Sunitinib—kidney cancer	0.00836	0.00868	CcSEcCtD
Terconazole—Chills—Pazopanib—kidney cancer	0.00815	0.00846	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Sorafenib—kidney cancer	0.00811	0.00841	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Sunitinib—kidney cancer	0.0078	0.00809	CcSEcCtD
Terconazole—Influenza like illness—Paclitaxel—kidney cancer	0.00779	0.00808	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Dactinomycin—kidney cancer	0.00738	0.00766	CcSEcCtD
Terconazole—Arthralgia—Temsirolimus—kidney cancer	0.00715	0.00742	CcSEcCtD
Terconazole—Myalgia—Temsirolimus—kidney cancer	0.00715	0.00742	CcSEcCtD
Terconazole—Anaphylactic shock—Temsirolimus—kidney cancer	0.00685	0.00711	CcSEcCtD
Terconazole—Myalgia—Pazopanib—kidney cancer	0.00673	0.00699	CcSEcCtD
Terconazole—Arthralgia—Pazopanib—kidney cancer	0.00673	0.00699	CcSEcCtD
Terconazole—Face oedema—Gemcitabine—kidney cancer	0.00671	0.00696	CcSEcCtD
Terconazole—Chills—Everolimus—kidney cancer	0.00644	0.00668	CcSEcCtD
Terconazole—Influenza like illness—Capecitabine—kidney cancer	0.00639	0.00663	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Gemcitabine—kidney cancer	0.00626	0.00649	CcSEcCtD
Terconazole—Ketoconazole—CYP1A1—kidney cancer	0.00625	0.173	CrCbGaD
Terconazole—Musculoskeletal discomfort—Temsirolimus—kidney cancer	0.00624	0.00648	CcSEcCtD
Terconazole—Chills—Erlotinib—kidney cancer	0.00621	0.00644	CcSEcCtD
Terconazole—Bronchospasm—Gemcitabine—kidney cancer	0.00591	0.00613	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Pazopanib—kidney cancer	0.00588	0.0061	CcSEcCtD
Terconazole—Pain—Temsirolimus—kidney cancer	0.00586	0.00608	CcSEcCtD
Terconazole—Ill-defined disorder—Vinblastine—kidney cancer	0.00582	0.00603	CcSEcCtD
Terconazole—Ill-defined disorder—Everolimus—kidney cancer	0.00579	0.00601	CcSEcCtD
Terconazole—Malaise—Vinblastine—kidney cancer	0.00565	0.00587	CcSEcCtD
Terconazole—Malaise—Everolimus—kidney cancer	0.00563	0.00584	CcSEcCtD
Terconazole—Gastrointestinal pain—Temsirolimus—kidney cancer	0.0056	0.00581	CcSEcCtD
Terconazole—Itraconazole—ABCB1—kidney cancer	0.00554	0.154	CrCbGaD
Terconazole—Pain—Pazopanib—kidney cancer	0.00552	0.00573	CcSEcCtD
Terconazole—Body temperature increased—Temsirolimus—kidney cancer	0.00542	0.00562	CcSEcCtD
Terconazole—Abdominal pain—Temsirolimus—kidney cancer	0.00542	0.00562	CcSEcCtD
Terconazole—Chills—Sunitinib—kidney cancer	0.00538	0.00558	CcSEcCtD
Terconazole—Arthralgia—Everolimus—kidney cancer	0.00532	0.00552	CcSEcCtD
Terconazole—Myalgia—Everolimus—kidney cancer	0.00532	0.00552	CcSEcCtD
Terconazole—Gastrointestinal pain—Pazopanib—kidney cancer	0.00528	0.00548	CcSEcCtD
Terconazole—Discomfort—Vinblastine—kidney cancer	0.00527	0.00547	CcSEcCtD
Terconazole—Discomfort—Everolimus—kidney cancer	0.00525	0.00545	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Paclitaxel—kidney cancer	0.00524	0.00544	CcSEcCtD
Terconazole—Myalgia—Erlotinib—kidney cancer	0.00513	0.00532	CcSEcCtD
Terconazole—Arthralgia—Erlotinib—kidney cancer	0.00513	0.00532	CcSEcCtD
Terconazole—Abdominal pain—Pazopanib—kidney cancer	0.0051	0.00529	CcSEcCtD
Terconazole—Chills—Dactinomycin—kidney cancer	0.00509	0.00528	CcSEcCtD
Terconazole—Hypersensitivity—Temsirolimus—kidney cancer	0.00505	0.00524	CcSEcCtD
Terconazole—Asthenia—Temsirolimus—kidney cancer	0.00492	0.0051	CcSEcCtD
Terconazole—Pruritus—Temsirolimus—kidney cancer	0.00485	0.00503	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00464	0.00482	CcSEcCtD
Terconazole—Asthenia—Pazopanib—kidney cancer	0.00463	0.0048	CcSEcCtD
Terconazole—Arthralgia—Sorafenib—kidney cancer	0.00462	0.00479	CcSEcCtD
Terconazole—Myalgia—Sorafenib—kidney cancer	0.00462	0.00479	CcSEcCtD
Terconazole—Face oedema—Capecitabine—kidney cancer	0.00461	0.00478	CcSEcCtD
Terconazole—Ill-defined disorder—Dactinomycin—kidney cancer	0.00458	0.00475	CcSEcCtD
Terconazole—Pruritus—Pazopanib—kidney cancer	0.00457	0.00474	CcSEcCtD
Terconazole—Dizziness—Temsirolimus—kidney cancer	0.00453	0.0047	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00448	0.00465	CcSEcCtD
Terconazole—Malaise—Dactinomycin—kidney cancer	0.00445	0.00462	CcSEcCtD
Terconazole—Arthralgia—Sunitinib—kidney cancer	0.00444	0.00461	CcSEcCtD
Terconazole—Myalgia—Sunitinib—kidney cancer	0.00444	0.00461	CcSEcCtD
Terconazole—Anaphylactic shock—Sorafenib—kidney cancer	0.00442	0.00459	CcSEcCtD
Terconazole—Pain—Vinblastine—kidney cancer	0.00438	0.00454	CcSEcCtD
Terconazole—Pain—Everolimus—kidney cancer	0.00436	0.00452	CcSEcCtD
Terconazole—Vomiting—Temsirolimus—kidney cancer	0.00436	0.00452	CcSEcCtD
Terconazole—Rash—Temsirolimus—kidney cancer	0.00432	0.00448	CcSEcCtD
Terconazole—Dermatitis—Temsirolimus—kidney cancer	0.00432	0.00448	CcSEcCtD
Terconazole—Chills—Gemcitabine—kidney cancer	0.00431	0.00448	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.0043	0.00446	CcSEcCtD
Terconazole—Headache—Temsirolimus—kidney cancer	0.00429	0.00445	CcSEcCtD
Terconazole—Dizziness—Pazopanib—kidney cancer	0.00427	0.00443	CcSEcCtD
Terconazole—Feeling abnormal—Vinblastine—kidney cancer	0.00422	0.00437	CcSEcCtD
Terconazole—Pain—Erlotinib—kidney cancer	0.00421	0.00436	CcSEcCtD
Terconazole—Myalgia—Dactinomycin—kidney cancer	0.0042	0.00436	CcSEcCtD
Terconazole—Feeling abnormal—Everolimus—kidney cancer	0.0042	0.00436	CcSEcCtD
Terconazole—Gastrointestinal pain—Vinblastine—kidney cancer	0.00418	0.00434	CcSEcCtD
Terconazole—Gastrointestinal pain—Everolimus—kidney cancer	0.00417	0.00432	CcSEcCtD
Terconazole—Discomfort—Dactinomycin—kidney cancer	0.00415	0.00431	CcSEcCtD
Terconazole—Influenza like illness—Doxorubicin—kidney cancer	0.00412	0.00427	CcSEcCtD
Terconazole—Vomiting—Pazopanib—kidney cancer	0.0041	0.00426	CcSEcCtD
Terconazole—Rash—Pazopanib—kidney cancer	0.00407	0.00422	CcSEcCtD
Terconazole—Nausea—Temsirolimus—kidney cancer	0.00407	0.00422	CcSEcCtD
Terconazole—Dermatitis—Pazopanib—kidney cancer	0.00407	0.00422	CcSEcCtD
Terconazole—Bronchospasm—Capecitabine—kidney cancer	0.00406	0.00421	CcSEcCtD
Terconazole—Abdominal pain—Vinblastine—kidney cancer	0.00404	0.0042	CcSEcCtD
Terconazole—Headache—Pazopanib—kidney cancer	0.00404	0.0042	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00403	0.00418	CcSEcCtD
Terconazole—Abdominal pain—Everolimus—kidney cancer	0.00403	0.00418	CcSEcCtD
Terconazole—Body temperature increased—Everolimus—kidney cancer	0.00403	0.00418	CcSEcCtD
Terconazole—Gastrointestinal pain—Erlotinib—kidney cancer	0.00402	0.00417	CcSEcCtD
Terconazole—Abdominal pain—Erlotinib—kidney cancer	0.00389	0.00403	CcSEcCtD
Terconazole—Body temperature increased—Erlotinib—kidney cancer	0.00389	0.00403	CcSEcCtD
Terconazole—Ill-defined disorder—Gemcitabine—kidney cancer	0.00388	0.00403	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00388	0.00402	CcSEcCtD
Terconazole—Nausea—Pazopanib—kidney cancer	0.00383	0.00398	CcSEcCtD
Terconazole—Pain—Sorafenib—kidney cancer	0.00378	0.00393	CcSEcCtD
Terconazole—Malaise—Gemcitabine—kidney cancer	0.00377	0.00392	CcSEcCtD
Terconazole—Hypersensitivity—Vinblastine—kidney cancer	0.00377	0.00391	CcSEcCtD
Terconazole—Myalgia—Vincristine—kidney cancer	0.00376	0.0039	CcSEcCtD
Terconazole—Hypersensitivity—Everolimus—kidney cancer	0.00376	0.0039	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00367	0.00381	CcSEcCtD
Terconazole—Asthenia—Vinblastine—kidney cancer	0.00367	0.00381	CcSEcCtD
Terconazole—Asthenia—Everolimus—kidney cancer	0.00366	0.00379	CcSEcCtD
Terconazole—Pain—Sunitinib—kidney cancer	0.00364	0.00378	CcSEcCtD
Terconazole—Gastrointestinal pain—Sorafenib—kidney cancer	0.00362	0.00375	CcSEcCtD
Terconazole—Chills—Paclitaxel—kidney cancer	0.00361	0.00375	CcSEcCtD
Terconazole—Pruritus—Everolimus—kidney cancer	0.00361	0.00374	CcSEcCtD
Terconazole—Anaphylactic shock—Vincristine—kidney cancer	0.0036	0.00374	CcSEcCtD
Terconazole—Myalgia—Gemcitabine—kidney cancer	0.00356	0.0037	CcSEcCtD
Terconazole—Arthralgia—Gemcitabine—kidney cancer	0.00356	0.0037	CcSEcCtD
Terconazole—Asthenia—Erlotinib—kidney cancer	0.00353	0.00366	CcSEcCtD
Terconazole—Discomfort—Gemcitabine—kidney cancer	0.00352	0.00365	CcSEcCtD
Terconazole—Urticaria—Sorafenib—kidney cancer	0.00351	0.00365	CcSEcCtD
Terconazole—Abdominal pain—Sorafenib—kidney cancer	0.0035	0.00363	CcSEcCtD
Terconazole—Body temperature increased—Sorafenib—kidney cancer	0.0035	0.00363	CcSEcCtD
Terconazole—Gastrointestinal pain—Sunitinib—kidney cancer	0.00348	0.00361	CcSEcCtD
Terconazole—Pruritus—Erlotinib—kidney cancer	0.00348	0.00361	CcSEcCtD
Terconazole—Pain—Dactinomycin—kidney cancer	0.00345	0.00358	CcSEcCtD
Terconazole—Anaphylactic shock—Gemcitabine—kidney cancer	0.00342	0.00354	CcSEcCtD
Terconazole—Dizziness—Vinblastine—kidney cancer	0.00338	0.00351	CcSEcCtD
Terconazole—Dizziness—Everolimus—kidney cancer	0.00337	0.0035	CcSEcCtD
Terconazole—Abdominal pain—Sunitinib—kidney cancer	0.00337	0.00349	CcSEcCtD
Terconazole—Body temperature increased—Sunitinib—kidney cancer	0.00337	0.00349	CcSEcCtD
Terconazole—Feeling abnormal—Dactinomycin—kidney cancer	0.00332	0.00345	CcSEcCtD
Terconazole—Ketoconazole—ABCB1—kidney cancer	0.00332	0.092	CrCbGaD
Terconazole—Gastrointestinal pain—Dactinomycin—kidney cancer	0.0033	0.00342	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00328	0.0034	CcSEcCtD
Terconazole—Hypersensitivity—Sorafenib—kidney cancer	0.00326	0.00338	CcSEcCtD
Terconazole—Vomiting—Vinblastine—kidney cancer	0.00325	0.00338	CcSEcCtD
Terconazole—Dizziness—Erlotinib—kidney cancer	0.00325	0.00337	CcSEcCtD
Terconazole—Ill-defined disorder—Paclitaxel—kidney cancer	0.00325	0.00337	CcSEcCtD
Terconazole—Vomiting—Everolimus—kidney cancer	0.00324	0.00336	CcSEcCtD
Terconazole—Rash—Everolimus—kidney cancer	0.00321	0.00333	CcSEcCtD
Terconazole—Dermatitis—Everolimus—kidney cancer	0.00321	0.00333	CcSEcCtD
Terconazole—Headache—Vinblastine—kidney cancer	0.00321	0.00333	CcSEcCtD
Terconazole—Headache—Everolimus—kidney cancer	0.00319	0.00331	CcSEcCtD
Terconazole—Body temperature increased—Dactinomycin—kidney cancer	0.00319	0.00331	CcSEcCtD
Terconazole—Abdominal pain—Dactinomycin—kidney cancer	0.00319	0.00331	CcSEcCtD
Terconazole—Asthenia—Sorafenib—kidney cancer	0.00317	0.00329	CcSEcCtD
Terconazole—Malaise—Paclitaxel—kidney cancer	0.00316	0.00328	CcSEcCtD
Terconazole—Hypersensitivity—Sunitinib—kidney cancer	0.00314	0.00325	CcSEcCtD
Terconazole—Pruritus—Sorafenib—kidney cancer	0.00313	0.00325	CcSEcCtD
Terconazole—Vomiting—Erlotinib—kidney cancer	0.00313	0.00324	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00311	0.00323	CcSEcCtD
Terconazole—Rash—Erlotinib—kidney cancer	0.0031	0.00322	CcSEcCtD
Terconazole—Dermatitis—Erlotinib—kidney cancer	0.0031	0.00321	CcSEcCtD
Terconazole—Headache—Erlotinib—kidney cancer	0.00308	0.0032	CcSEcCtD
Terconazole—Pain—Vincristine—kidney cancer	0.00308	0.00319	CcSEcCtD
Terconazole—Asthenia—Sunitinib—kidney cancer	0.00305	0.00317	CcSEcCtD
Terconazole—Nausea—Vinblastine—kidney cancer	0.00304	0.00315	CcSEcCtD
Terconazole—Nausea—Everolimus—kidney cancer	0.00303	0.00314	CcSEcCtD
Terconazole—Pruritus—Sunitinib—kidney cancer	0.00301	0.00312	CcSEcCtD
Terconazole—Arthralgia—Paclitaxel—kidney cancer	0.00298	0.0031	CcSEcCtD
Terconazole—Myalgia—Paclitaxel—kidney cancer	0.00298	0.0031	CcSEcCtD
Terconazole—Face oedema—Doxorubicin—kidney cancer	0.00297	0.00308	CcSEcCtD
Terconazole—Hypersensitivity—Dactinomycin—kidney cancer	0.00297	0.00308	CcSEcCtD
Terconazole—Chills—Capecitabine—kidney cancer	0.00296	0.00308	CcSEcCtD
Terconazole—Discomfort—Paclitaxel—kidney cancer	0.00295	0.00306	CcSEcCtD
Terconazole—Gastrointestinal pain—Vincristine—kidney cancer	0.00294	0.00305	CcSEcCtD
Terconazole—Dizziness—Sorafenib—kidney cancer	0.00293	0.00304	CcSEcCtD
Terconazole—Pain—Gemcitabine—kidney cancer	0.00292	0.00303	CcSEcCtD
Terconazole—Nausea—Erlotinib—kidney cancer	0.00292	0.00303	CcSEcCtD
Terconazole—Asthenia—Dactinomycin—kidney cancer	0.00289	0.003	CcSEcCtD
Terconazole—Anaphylactic shock—Paclitaxel—kidney cancer	0.00286	0.00297	CcSEcCtD
Terconazole—Abdominal pain—Vincristine—kidney cancer	0.00285	0.00295	CcSEcCtD
Terconazole—Body temperature increased—Vincristine—kidney cancer	0.00285	0.00295	CcSEcCtD
Terconazole—Dizziness—Sunitinib—kidney cancer	0.00282	0.00292	CcSEcCtD
Terconazole—Feeling abnormal—Gemcitabine—kidney cancer	0.00281	0.00292	CcSEcCtD
Terconazole—Vomiting—Sorafenib—kidney cancer	0.00281	0.00292	CcSEcCtD
Terconazole—Rash—Sorafenib—kidney cancer	0.00279	0.00289	CcSEcCtD
Terconazole—Dermatitis—Sorafenib—kidney cancer	0.00279	0.00289	CcSEcCtD
Terconazole—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00277	0.00288	CcSEcCtD
Terconazole—Headache—Sorafenib—kidney cancer	0.00277	0.00288	CcSEcCtD
Terconazole—Vomiting—Sunitinib—kidney cancer	0.00271	0.00281	CcSEcCtD
Terconazole—Body temperature increased—Gemcitabine—kidney cancer	0.0027	0.0028	CcSEcCtD
Terconazole—Rash—Sunitinib—kidney cancer	0.00268	0.00278	CcSEcCtD
Terconazole—Dermatitis—Sunitinib—kidney cancer	0.00268	0.00278	CcSEcCtD
Terconazole—Ill-defined disorder—Capecitabine—kidney cancer	0.00267	0.00277	CcSEcCtD
Terconazole—Headache—Sunitinib—kidney cancer	0.00267	0.00277	CcSEcCtD
Terconazole—Hypersensitivity—Vincristine—kidney cancer	0.00265	0.00275	CcSEcCtD
Terconazole—Nausea—Sorafenib—kidney cancer	0.00263	0.00273	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00261	0.0027	CcSEcCtD
Terconazole—Malaise—Capecitabine—kidney cancer	0.00259	0.00269	CcSEcCtD
Terconazole—Asthenia—Vincristine—kidney cancer	0.00258	0.00268	CcSEcCtD
Terconazole—Vomiting—Dactinomycin—kidney cancer	0.00256	0.00266	CcSEcCtD
Terconazole—Rash—Dactinomycin—kidney cancer	0.00254	0.00264	CcSEcCtD
Terconazole—Nausea—Sunitinib—kidney cancer	0.00253	0.00262	CcSEcCtD
Terconazole—Asthenia—Gemcitabine—kidney cancer	0.00245	0.00254	CcSEcCtD
Terconazole—Myalgia—Capecitabine—kidney cancer	0.00245	0.00254	CcSEcCtD
Terconazole—Arthralgia—Capecitabine—kidney cancer	0.00245	0.00254	CcSEcCtD
Terconazole—Pain—Paclitaxel—kidney cancer	0.00245	0.00254	CcSEcCtD
Terconazole—Discomfort—Capecitabine—kidney cancer	0.00242	0.00251	CcSEcCtD
Terconazole—Pruritus—Gemcitabine—kidney cancer	0.00242	0.00251	CcSEcCtD
Terconazole—Nausea—Dactinomycin—kidney cancer	0.00239	0.00248	CcSEcCtD
Terconazole—Dizziness—Vincristine—kidney cancer	0.00238	0.00247	CcSEcCtD
Terconazole—Feeling abnormal—Paclitaxel—kidney cancer	0.00236	0.00245	CcSEcCtD
Terconazole—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00234	0.00243	CcSEcCtD
Terconazole—Vomiting—Vincristine—kidney cancer	0.00229	0.00238	CcSEcCtD
Terconazole—Urticaria—Paclitaxel—kidney cancer	0.00227	0.00236	CcSEcCtD
Terconazole—Rash—Vincristine—kidney cancer	0.00227	0.00236	CcSEcCtD
Terconazole—Dermatitis—Vincristine—kidney cancer	0.00227	0.00235	CcSEcCtD
Terconazole—Body temperature increased—Paclitaxel—kidney cancer	0.00226	0.00235	CcSEcCtD
Terconazole—Abdominal pain—Paclitaxel—kidney cancer	0.00226	0.00235	CcSEcCtD
Terconazole—Headache—Vincristine—kidney cancer	0.00226	0.00234	CcSEcCtD
Terconazole—Vomiting—Gemcitabine—kidney cancer	0.00217	0.00225	CcSEcCtD
Terconazole—Rash—Gemcitabine—kidney cancer	0.00215	0.00223	CcSEcCtD
Terconazole—Dermatitis—Gemcitabine—kidney cancer	0.00215	0.00223	CcSEcCtD
Terconazole—Headache—Gemcitabine—kidney cancer	0.00214	0.00222	CcSEcCtD
Terconazole—Nausea—Vincristine—kidney cancer	0.00214	0.00222	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.00214	0.00222	CcSEcCtD
Terconazole—Hypersensitivity—Paclitaxel—kidney cancer	0.00211	0.00219	CcSEcCtD
Terconazole—Asthenia—Paclitaxel—kidney cancer	0.00205	0.00213	CcSEcCtD
Terconazole—Nausea—Gemcitabine—kidney cancer	0.00203	0.00211	CcSEcCtD
Terconazole—Pruritus—Paclitaxel—kidney cancer	0.00202	0.0021	CcSEcCtD
Terconazole—Pain—Capecitabine—kidney cancer	0.00201	0.00208	CcSEcCtD
Terconazole—Feeling abnormal—Capecitabine—kidney cancer	0.00193	0.00201	CcSEcCtD
Terconazole—Gastrointestinal pain—Capecitabine—kidney cancer	0.00192	0.00199	CcSEcCtD
Terconazole—Chills—Doxorubicin—kidney cancer	0.00191	0.00198	CcSEcCtD
Terconazole—Dizziness—Paclitaxel—kidney cancer	0.00189	0.00196	CcSEcCtD
Terconazole—Urticaria—Capecitabine—kidney cancer	0.00186	0.00193	CcSEcCtD
Terconazole—Abdominal pain—Capecitabine—kidney cancer	0.00186	0.00192	CcSEcCtD
Terconazole—Body temperature increased—Capecitabine—kidney cancer	0.00186	0.00192	CcSEcCtD
Terconazole—Vomiting—Paclitaxel—kidney cancer	0.00182	0.00189	CcSEcCtD
Terconazole—Rash—Paclitaxel—kidney cancer	0.0018	0.00187	CcSEcCtD
Terconazole—Dermatitis—Paclitaxel—kidney cancer	0.0018	0.00187	CcSEcCtD
Terconazole—Headache—Paclitaxel—kidney cancer	0.00179	0.00186	CcSEcCtD
Terconazole—Hypersensitivity—Capecitabine—kidney cancer	0.00173	0.00179	CcSEcCtD
Terconazole—Ill-defined disorder—Doxorubicin—kidney cancer	0.00172	0.00178	CcSEcCtD
Terconazole—Nausea—Paclitaxel—kidney cancer	0.0017	0.00176	CcSEcCtD
Terconazole—Asthenia—Capecitabine—kidney cancer	0.00168	0.00175	CcSEcCtD
Terconazole—Malaise—Doxorubicin—kidney cancer	0.00167	0.00173	CcSEcCtD
Terconazole—Pruritus—Capecitabine—kidney cancer	0.00166	0.00172	CcSEcCtD
Terconazole—Arthralgia—Doxorubicin—kidney cancer	0.00158	0.00164	CcSEcCtD
Terconazole—Myalgia—Doxorubicin—kidney cancer	0.00158	0.00164	CcSEcCtD
Terconazole—Discomfort—Doxorubicin—kidney cancer	0.00156	0.00162	CcSEcCtD
Terconazole—Dizziness—Capecitabine—kidney cancer	0.00155	0.00161	CcSEcCtD
Terconazole—Anaphylactic shock—Doxorubicin—kidney cancer	0.00151	0.00157	CcSEcCtD
Terconazole—Vomiting—Capecitabine—kidney cancer	0.00149	0.00155	CcSEcCtD
Terconazole—Rash—Capecitabine—kidney cancer	0.00148	0.00154	CcSEcCtD
Terconazole—Dermatitis—Capecitabine—kidney cancer	0.00148	0.00153	CcSEcCtD
Terconazole—Headache—Capecitabine—kidney cancer	0.00147	0.00153	CcSEcCtD
Terconazole—Nausea—Capecitabine—kidney cancer	0.00139	0.00145	CcSEcCtD
Terconazole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.00138	0.00143	CcSEcCtD
Terconazole—Pain—Doxorubicin—kidney cancer	0.00129	0.00134	CcSEcCtD
Terconazole—Feeling abnormal—Doxorubicin—kidney cancer	0.00125	0.00129	CcSEcCtD
Terconazole—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00124	0.00128	CcSEcCtD
Terconazole—Urticaria—Doxorubicin—kidney cancer	0.0012	0.00125	CcSEcCtD
Terconazole—Abdominal pain—Doxorubicin—kidney cancer	0.0012	0.00124	CcSEcCtD
Terconazole—Body temperature increased—Doxorubicin—kidney cancer	0.0012	0.00124	CcSEcCtD
Terconazole—Hypersensitivity—Doxorubicin—kidney cancer	0.00111	0.00116	CcSEcCtD
Terconazole—Asthenia—Doxorubicin—kidney cancer	0.00109	0.00113	CcSEcCtD
Terconazole—Pruritus—Doxorubicin—kidney cancer	0.00107	0.00111	CcSEcCtD
Terconazole—Dizziness—Doxorubicin—kidney cancer	0.001	0.00104	CcSEcCtD
Terconazole—Vomiting—Doxorubicin—kidney cancer	0.000962	0.000998	CcSEcCtD
Terconazole—Rash—Doxorubicin—kidney cancer	0.000954	0.00099	CcSEcCtD
Terconazole—Dermatitis—Doxorubicin—kidney cancer	0.000953	0.000989	CcSEcCtD
Terconazole—Headache—Doxorubicin—kidney cancer	0.000948	0.000983	CcSEcCtD
Terconazole—Nausea—Doxorubicin—kidney cancer	0.000899	0.000932	CcSEcCtD
